Agnuside

Agnuside
Product Name Agnuside
CAS No.: 11027-63-7
Catalog No.: CFN99203
Molecular Formula: C22H26O11
Molecular Weight: 466.4 g/mol
Purity: >=98%
Type of Compound: Iridoids
Physical Desc.: Powder
Targets: TNF-α | PGE | LTB | IL Receptor | IFN-γ
Source: The herbs of Vitex negundo L.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $158/10mg
Agnuside has anti-arthritic activity, it also shows inhibition of vascular permeability and leukocyte migration in vivo.It inhibited an array of pro-inflammatory mediators (PGE(2) and LTB(4)) and T-cell-mediated cytokines (IL-2, TNF-α, IFN-γ, IL-4, IL-10, IL-17).
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Food and Bioprocess TechnologyJune 2017
  • Molecules. 2017 Feb 21;
  • Nat Plants. 2016 Dec 22
  • Evid Based Complement Alternat Med. 2017:1583185
  • Separation Science and Technology2016 Mar,23
  • Oncotarget. 2017 Dec 23;
  • Pharm Biol. 2015 Oct 1
  • Journal of Pharmaceutical Analysis2016 Dec.
  • Polytechnic University of Catalonia2016
  • Am J Chin Med.2016;44(6)
  • Aucubin

    Catalog No: CFN98530
    CAS No: 479-98-1
    Price: $100/20mg
    6-O-p-Hydroxybenzoylaucubin

    Catalog No: CFN99031
    CAS No: 1016987-87-3
    Price: Inquiry(manager@chemfaces.com)
    Agnuside

    Catalog No: CFN99203
    CAS No: 11027-63-7
    Price: $158/10mg
    10-O-Vanilloylaucubin

    Catalog No: CFN99891
    CAS No: 193969-08-3
    Price: Inquiry(manager@chemfaces.com)
    Rhmannioside D

    Catalog No: CFN90216
    CAS No: 81720-08-3
    Price: $318/20mg
    Inflamm Res. 2012 Apr;61(4):293-304.
    Anti-arthritic activity of agnuside mediated through the down-regulation of inflammatory mediators and cytokines.[Pubmed: 22228102]
    The purpose of this study was to elucidate the probable mechanism for the anti-arthritic activity of Agnuside (AGN), a compound isolated from the leaf extract of Vitex negundo.
    METHODS AND RESULTS:
    The anti-inflammatory activity of AGN within a dose range of 1.56-12.50 mg/kg in normal and adrenalectomized rats was evaluated against different inflammagens. An array of pro-inflammatory mediators (PGE(2) and LTB(4)) and T-cell-mediated cytokines (IL-2, TNF-α, IFN-γ, IL-4, IL-10, IL-17) was assayed using flow cytometry, in arthritic paw tissue homogenate and splenocytes of treated animals. Significant anti-arthritic activity was observed in the polyarthritis test in rats and this was associated with significant suppression of inflammatory mediators and T-cell-mediated cytokines (Th1/Th2). The anti-inflammatory activity in adrenalectomized rats confirmed that the effect of AGN is not mediated by the pituitary-adrenal axis. AGN also showed inhibition of vascular permeability and leukocyte migration in vivo.
    CONCLUSIONS:
    The study suggests the possible development of AGN as a therapeutic agent in the treatment of arthritis by the modulation of the host immune response.
    Inflamm Res. 2012 Apr;61(4):293-304.
    Anti-arthritic activity of agnuside mediated through the down-regulation of inflammatory mediators and cytokines.[Pubmed: 22228102]
    Animal Models: Fourteen-week-old Wistar rats (150–180 g) and 12-weekold Swiss albino mice (24–30 g)
    Formulation: A suspension in gumacacia (1% w/v)
    Dosages: 1.56, 3.12, 6.25, 12.50 mg/kg
    Administration: p.o.
    Glycitein

    Catalog No: CFN99106
    CAS No: 40957-83-3
    Price: $128/20mg
    Loliolid

    Catalog No: CFN92750
    CAS No: 5989-02-6
    Price: $388/5mg
    Ginsenoside Rk2

    Catalog No: CFN92818
    CAS No: 364779-14-6
    Price: $498/10mg
    7,2',4'-Trihydroxy-5-methoxy-3-phenylcoumarin

    Catalog No: CFN96001
    CAS No: 1092952-62-9
    Price: $413/5mg
    Hypaphorine

    Catalog No: CFN90634
    CAS No: 487-58-1
    Price: $198/20mg
    Ganoderic acid G

    Catalog No: CFN90801
    CAS No: 98665-22-6
    Price: $400/10mg
    Gelidoside

    Catalog No: CFN89019
    CAS No: 128420-44-0
    Price: $288/10mg
    1-O-galloyl-6-O-cinnamoylglucose

    Catalog No: CFN95053
    CAS No: 115746-69-5
    Price: $338/5mg
    Cyclo(Hyp-Val)

    Catalog No: CFN91062
    CAS No: 1425501-89-8
    Price: $332/10mg
    Cistantubuloside C1

    Catalog No: CFN95121
    CAS No: 620632-36-2
    Price: $298/10mg